Literature DB >> 11781127

Utilization of lipid-lowering drugs in men and women. a reflection of the research evidence?

Isabelle Savoie1, Arminée Kazanjian.   

Abstract

This study analyzes the utilization of statin lipid-lowering drugs in a Canadian province using a population-wide drug prescription database. The utilization pattern is compared to the results of a systematic review of randomized controlled trials on their effectiveness. The study found that 74.7% of individuals prescribed a statin had no reported history of coronary heart disease (CHD). Women without CHD formed 23.1% of statins recipients; 32.9% of individuals filling a statin prescription were age 70 and over. Only 15.3% of men with CHD had been prescribed a statin. Based on the systematic review, 88.7% of the utilization of statins in this Canadian province was not supported by the results of the systematic review. Considering baseline lipid-levels does not substantially alter these findings. This study concludes that statins prescribing practices need to be realigned with research evidence. This implies refocusing utilization away from women and the elderly, towards men with CHD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781127     DOI: 10.1016/s0895-4356(01)00436-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

1.  Statin use after acute myocardial infarction: a nationwide study in Denmark.

Authors:  Jeppe N Rasmussen; Gunnar H Gislason; Steen Z Abildstrom; Søren Rasmussen; Ida Gustafsson; Pernille Buch; Jens Friberg; Lars Køber; Christian Torp-Pedersen; Mette Madsen; Steen Stender
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Statin use in Canadians: trends, determinants and persistence.

Authors:  C Ineke Neutel; Howard Morrison; Norm R C Campbell; Margaret de Groh
Journal:  Can J Public Health       Date:  2007 Sep-Oct

3.  Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.

Authors:  Ingeborg Hartz; Anne Elise Eggen; Sameline Grimsgaard; Frode Skjold; Inger Njølstad
Journal:  Eur J Clin Pharmacol       Date:  2004-09-29       Impact factor: 2.953

4.  Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision.

Authors:  G Trifirò; M Alacqua; S Corrao; S Moretti; D U Tari; M Galdo; A P Caputi; V Arcoraci
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

5.  Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study.

Authors:  D Macías Saint-Gerons; C de la Fuente Honrubia; D Montero Corominas; M J Gil; F de Andrés-Trelles; F Catalá-López
Journal:  Eur J Clin Pharmacol       Date:  2013-09-24       Impact factor: 2.953

Review 6.  Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.

Authors:  Catherine Kim; Timothy P Hofer; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

7.  Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.

Authors:  Ferdinando Carlo Sasso; Nadia Lascar; Antonella Ascione; Ornella Carbonara; Luca De Nicola; Roberto Minutolo; Teresa Salvatore; Maria Rosaria Rizzo; Plinio Cirillo; Giuseppe Paolisso; Raffaele Marfella
Journal:  Cardiovasc Diabetol       Date:  2016-10-13       Impact factor: 9.951

8.  Health Care Utilization by Canadian Women.

Authors:  Arminée Kazanjian; Denise Morettin; Robert Cho
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

9.  Factors Associated with Women's Medication Use.

Authors:  Jennifer Payne; Ineke Neutel; Robert Cho; Marie DesMeules
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

10.  Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?

Authors:  Carmen Ferrajolo; Vincenzo Arcoraci; Maria Giuseppa Sullo; Concetta Rafaniello; Liberata Sportiello; Rosarita Ferrara; Angelo Cannata; Claudia Pagliaro; Michele Giuseppe Tari; Achille Patrizio Caputi; Francesco Rossi; Gianluca Trifirò; Annalisa Capuano
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.